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Background. Pancytopenia has multiple etiologies like megaloblastic anemia, aplastic anemia, leukemia, and various infections. We
investigated the clinical, etiological and hematological proﬁle including bone marrow morphology of patients with pancytopenia
in relation to their vitamin B12 and folic acid status at a tertiary care referral hospital in north India. Methods. A total of 140
consecutive patients with pancytopenia were selected from June 2007 to December 2008. Bone marrow examination and other
tests were carried out as warranted, including serum cobalamin and folate assays using liquid chromatography mass spectroscopy
(LC MS/MS). Results. The study population consisted of 92 males and 48 females with a mean age of 32.8 years. Megaloblastic
anemia 60.7%, aplastic anemia (7.8%), and leukemia (9.2%) were common causes. Infectious causes (16.4% of all cases) included
leishmaniasis, HIV–AIDS, malaria and tuberculosis. Severe cobalamin deﬁciency (B12 < 100pg/mL) was seen in 81% of all
patients including 91.6% of patients with MA. In contrast, only 7.14% of all pancytopenic patients were folate deﬁcient. Folate
deﬁciency (<5ng/mL) was seen in just 5% MA patients. Combined cobalamin and folate deﬁciency was seen in 5 patients (3.51%).
Conclusion. Cobalamin deﬁciency was found to be more common in our setting and is largely underdiagnosed in the age of folate
supplementation. Infectious diseases like tuberculosis, leishmaniasis, and increasingly HIV are important and treatable causes of
pancytopenia. This is in contrast with the developed nations where the bulk of disease is due to malignancy or marrow aplasia.
1.Introduction
Pancytopenia is diagnosed when there is a reduction in all
three hematopoetic cell lines. This is seen as reduction in
the white cell count, hemoglobin, and platelet count which
is most often the result of bone marrow inﬁltration or
failure, anticancer chemotherapy, hypersplenism, systemic
diseases, and infections like HIV, tuberculosis, leishmaniasis,
and so forth [1, 2]. While there are several published
studies on the hematological diagnosis of pancytopenia on
basis of bone marrow morphology, few have attempted to
explore the underlying etiology and clinical course of the
disorders leading to this condition. In this study, we hoped
to evaluate the demographic, nutritional, socioeconomic
and age patterns of the myriad disorders which cause
pancytopenia and develop an approach to the diagnosis of
this condition in our patient population.
2.MaterialsandMethods
This prospective study comprised of adults drawn from the
outpatient/inpatient/emergency/referral services of Maulana
Azad Medical College, Lok Nayak Hospital and other asso-
ciated hospitals, a tertiary care referral centre in New Delhi,
north India. The period of observation was from June 2007
to December 2008. Overall, 160 consecutive patients were2 Anemia
recruited in the study with written informed consent. Of
these,20patientswereexcludedduetooneormoreexclusion
criteria. The inclusion criteria for the study were
(1) age > 18 years of either sex,
(2) pancytopenia as deﬁned by the presence of the
following:
(i) Hb < 10 gm/dL in female subjects and <11gm/
dL in male subjects,
(ii) Total leukocyte count < 4 × 109 cells/L,
(iii) Platelet count < 150 × 109/L.
The exclusion criteria for this study were
(1) cancer chemotherapy recipients or concomitant use
of colony stimulating factors,
(2) recipients of multiple blood/blood component trans-
fusions prior to presentation in our hospital,
(3) patients who were too sick to undergo the proposed
diagnostic workup.
2.1. Study Design. A questionnaire was used to document
demographic data, clinical presentation, dietary history, past
historyofanemia,bloodtransfusionsanddrugs,administra-
tionofhematinics,andbloodtransfusionsincludingtransfu-
sion of blood components and radiation exposure. This was
followedbyadetailedclinicalexamination,particularlymak-
ingnoteofpallor,jaundice,hepatomegaly,splenomegalyand
lymphadenopathy and other features peculiar to conditions
like B12-deﬁcient anemia like hyperpigmentation of skin,
knuckles, and so forth. Patient outcome and improvement
with followup was also documented for a period of at least
four months after discharge. The laboratory tests performed
were as follows.
Complete blood count (CBC) with a diﬀerential count
and red blood cell indices was estimated using the automatic
cell counter MS 9 Hematology Analyzer, (Melet Schloesing
Laboratories, USA). A blood ﬁlm was stained by the
Wright stain and evaluated for red cell morphology, band
forms, platelet morphology and number, and any atypical
cells/parasite. Reticulocyte count using 1% brilliant cresyl
blue for supravital staining was done. Liver function tests,
liver enzyme levels, renal function tests, serum ferritin and
lactate dehydrogenase (LDH) levels were also done in all
patients.
Bone Marrow Examination. Bone marrow aspiration and
wherever required, a trephine biopsy was performed. Biopsy
was required in case of dry tap, marrow ﬁbrosis, inadequate
ﬁrst aspirate, marrow aplasia, and hematological neoplasms.
Further tests were carried out as warranted by the clinical
context and the results of baseline investigations.
Vitamin B12 and Folate Assays. Blood was collected in
vacutainers with aseptic technique, centrifuged immediately
and serum samples were stored at −70◦C till assay was
done. The HPLC (high pressure liquid chromatography)
standard reagent for folic acid was procured from Qualigens
Pharmaceuticals and cyanocobalamin from Khemi Labs.
The samples were processed to get serum and solid phase
extraction was done by mixing 500µL of sample with
10µL of internal standard (sildenaﬁl) and processing with
solvent acetonitrile and distilled water through solid phase
extraction cartridges to procure the test samples for liquid
chromatography coupled to isotope dilution tandem mass
spectroscopy (LC-MS/MS).
The normal range of cobalamin was 200–700pg/mL and
folate was 5.0–15ng/mL. The method was calibrated using
20 control samples of asymptomatic individuals without
anemia. The normal range of vitamin B12 and folic acid
depends on the kind of assay used. Conventionally B12
estimation was done by microbiological assays, ELISAs
(enzyme linked immunosorbent assay), HPLC, or radioim-
munoassay (RIA). We used LC MS/MS for estimation of
both B12 and folate, which is now a candidate reference
method for vitamin estimation with good reproducibility
andreducedinterlaboratoryandintermethodologyvariation
[3, 4]. Other studies have reported the limits of detection of
folic acid in serum as 0.07nmol/L. Coeﬃcient of variation
for within and between run imprecision was <10% for
folate concentration >2nmol/L. Total folate concentration
determined by RIA was 9% lower than results obtained with
LC-MS/MS [5]. Another study for B12 estimation using LC-
MS/MS demonstrated speciﬁcity by the retention character-
istics and peak purity with the vitamin B12 standard. The
calibration graph plotted with six concentrations of vitamin
B12 showed a regression coeﬃcient R>0.9997. The relative
standard deviation was below 3.2% [6]. Homocysteine was
estimated in serum by conventional Enzyme Immunoassay
(EIA) method using commercially available kits (Bio-Rad
Laboratories Incorporated, India).
2.2. Statistics. The measurements obtained by the above-
mentioned studies were used to calculate mean values for
each patient and all cases as a whole. The Students’ t-test
was used for both independent variables. The paired sample
t-test was performed to compare the diﬀerence of means
between groups. P<0.05 was considered signiﬁcant. Data
was analysed with SPSS software version 13 (SPSS, Chicago,
IL, USA).
3. Observations andResults
The study population consisted of 140 patients with a mean
age of 32.8 years with range of 18–80 years. There were
92 males and 48 females in the study group (M:F ratio
1.9:1). More than half (59%) of all patients belonged to
a younger age group (18–30 years) including 56% of all
females and 55% of all males. Most of the patients (76.4%)
belonged to a lower socioeconomic status based on occu-
pation, income, and education. In our study, MA was the
largest group comprising 60.7% of all cases. Aplastic anemia
accounted for 7.8% while leukemia (including acute myeloid
leukemia,acutenonmyelogenousleukemia,undiﬀerentiated
leukemias, chronic myeloid leukemia in blast crisis, and one
case of lymphoma) accounted for 9.2% cases, respectively
(see Table 1).Anemia 3
Table 1: Etiological diagnosis in pancytopenia.
S. No. Diagnosis Females Males Total % of total
1 Megaloblastic anemia 40 45 85 60.7
2 Aplastic anemia 1 10 11 7.9
3 Acute leukemia† 01 1 1 17 . 9
4 HIV-AIDS 0 8 8 5.7
5K a l a a z a r 1 7 8 5 . 7
6 Chronic malaria 1 3 4 2.9
7 Disseminated tuberculosis 0 3 3 2.1
8 Chronic liver disease 2 0 2 1.4
9L y m p h o m a 0 1 1 0 . 7
10 Myelodysplastic syndrome 0 1 1 0.7
11 CML with blast crisis 0 1 1 0.7
12 Metastatic anaplastic carcinoma 0 1 1 0.7
13 Metastatic gastric carcinoma (signet cell) 1 0 1 0.7
14 Niemann Picks disease 0 1 1 0.7
15 Gaucher’s disease 1 0 1 0.7
16 Acute subdural hematoma with transient pancytopenia 1 0 1 0.7
Total 48 92 140 100
HIV-AIDS: human immunodeﬁciency virus-acquired immunodeﬁciency syndrome; CML: chronic myeloid leukemia.
†Includes 4 patients of myeloid leukemia and 4 patients of nonmyelogenous leukemia, 2 undiﬀerentiated leukemias, and one case of acute promyelocytic leu-
kemia.
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Figure 1: Clinicopathological diagnostic groups in pancytopenia.
Infectious causes accounted for 16.4% of all cases includ-
ing cases of kala azar (8), HIV-AIDS (8), chronic malaria
(4), and disseminated tuberculosis (3). There were two cases
of storage disorder including one case of Gaucher’s disease
and two cases of metastatic carcinoma. We also encountered
one case of myelodysplastic syndrome in our study. In the
older patient subgroup aged 31–80 years, there were 39
(75%) patients with MA, 4 (7.7%) with aplastic anemia, and
6 (11.5%) with infectious causes of pancytopenia. Aplastic
anemia was seen in patients in their 2nd or 3rd decade. They
were younger as compared to pancytopenics in the other
diagnostic groups (P = 0.001) (see Figures 1 and 2).
All patients were symptomatic, the common symptoms
beingeasyfatigability(98%),weightloss(66%),fever(67%),
abdominal fullness (72%), early satiety after meals (80%),
pain abdomen (66%), swelling of feet (26%), and shortness
of breath (27%). Anemia was severe enough to present as
pallor in all patients. About 17% of all patients had icterus
including 21.2% of patients with MA. In the group with
MA, 10.6% of patients had hyperpigmentation of skin while
18.8% of all patients had knuckle hyperpigmentation, which
was found to correlate signiﬁcantly with this diagnosis (P<
0.005). Glossitis (26%), angular cheilitis (13%), and pedal
edema (11%) were common in pancytopenia. Glossitis was
present in 36% of patients with MA. The largest splenic
enlargement was encountered in the category of infections
especially kala azar and the storage disorders. Another
signiﬁcant ﬁnding was that 16% of all pancytopenic patients
had no splenomegaly including 7% of MA and 23% of
leukemia patients.
One fourth of pancytopenia had a clinical bleed and a
quarter of them had bleeding from more than one site. Half
of the bleeding cases, that is, 18/35 (51%), occurred at a
platelet count of 50–100 × 109/L. The most common sites
of bleeding were bleeding per rectum and menorrhagia each
aﬀecting 11/140 (7.9%) patients. Epistaxis was a signiﬁcant
ﬁnding in patients of aplastic anemia aﬀecting 18% of these
cases. Up to 25% of women with MA had menorrhagia.
Skin bleeding (3.5%) and easy bruisability (4.7%) were also
noticed in the MA group. Up to 30.8% of patients with
leukemia had signiﬁcant postintervention bleeding from
central line sites or after marrow aspiration.
3.1. Hematological Parameters in Pancytopenia. Some inter-
esting correlates could be assessed from this study. The mean
hemoglobin level in all patients of pancytopenia was 5.3 ±
1.6g/dL. Mean Hb was just 3.8g/dL in the group of aplastic
anemia. Severe anemia (Hb < 5 g / d L )w a ss e e ni n4 0 %o f
MA, 72% of aplastic anemia, and 46% of patients with4 Anemia
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Figure 2: Age and gender distribution across diagnostic groups in pancytopenia.
Table 2: Hematological parameters in pancytopenia.
Megaloblastic anemia Aplastic anemia Leukemia Infections Myelophthisis Other All pancytopenia
Mean ± standard deviation
Hb (g/dL) 5.2 ±1.63 .8 ±1.75 .7 ±1.36 .1 ±1.35 .0 ±1.17 .4 ±0.75 .3 ±1.6
TLC (×109 cells/L) 2.63 ±0.88 2.16 ±0.65 2.88 ±0.91 2.66 ±0.69 2.58 ±0.10 3.31 ±0.35 2.64 ±0.84
Platelets (×109 cells/L) 82 ±35 47 ±20 84 ±14 100 ±23 70 ±31 73 ±19 82 ±32
ANC (×109 cells/L) 1.61 ±0.82 0.79 ±0.61 1.23 ±0.95 1.66 ±0.78 1.52 ±0.65 2.22 ±0.22 1.53 ±0.83
RDW 16.9 ±5.61 4 .9 ±2.31 5 .0 ±3.41 4 .8 ±4.81 4 .8 ±2.71 5 .0 ±2.01 6 .1 ±5.0
MCV (ﬂ) 95.1 ±14.79 0 .0 ±9.79 2 .1 ±7.18 5 .9 ±10.99 0 .9 ±3.39 4 .8 ±2.59 2 .8 ±13.1
MCH (pg) 27.7 ±2.72 8 .9 ±3.82 7 .5 ±2.52 6 .9 ±2.92 7 .3 ±3.32 4 .6 ±0.92 7 .5 ±2.8
MCHC 33.5 ±1.63 3 .4 ±2.33 2 .6 ±1.93 3 .4 ±1.23 3 .6 ±0.93 2 .6 ±1.23 3 .4 ±1.6
Retic count (%) 1.9 ±0.90 .7 ±0.21 .8 ±0.81 .5 ±0.92 .1 ±0.81 .5 ±0.61 .7 ±0.9
Hypersegmented neutrophils 24 (30.4%) 0 (0%) 1 (9.1%) 1 (5%) 1 (25%) 0 (0%) 27 (21.3%)
Macrocytosis 29 (34.1%) 1 (9.0%) 1 (7.6%) 3 (13.04%) 1 (25%) 0 (0%) 35 (25%)
Macroovalocytosis 29 (34.1%) 1 (9.0%) 0 (0%) 2 (8.69%) 0 (0%) 0 (0%) 32 (21.2%)
Hb: hemoglobin; TLC: total leukocyte count; AEC: absolute eosinophilcount; ANC: absolute neutrophilcount; RDW: red cell distribution width; MCV:mean
corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; Retic count: reticulocyte count.
leukemia. Aplastic anemia patients also had a signiﬁcantly
lower mean platelet count (42 × 109/L) as compared with
other pancytopenic patients (82 × 109/L). A platelet count of
<40 × 109/L correlated with a diagnosis of aplastic anemia
(P = 0.001). Likewise the absolute neutrophil count was
also markedly reduced in this group. The mean reticulocyte
count in this group was 0.71 as compared with 1.76 for other
pancytopenics. Macrocytosis (MCV ≥ 100ﬂ) was seen in
33%andmacroovalocytosisinanother34%ofMA.AnMCV
of >95ﬂ and an RDW ≥ 16 each correlated with a diagnosis
of MA (P = 0.001). Hypersegmentation (≥5 nuclear lobes
in neutrophils) was seen in 34% of MA and was a speciﬁc
ﬁnding.
3.2. Role of Bone Marrow Examination. Bone marrow ex-
amination corresponded with the clinical diagnosis in
126/140 patients, that is, almost 90%. Bone marrow aspirate
was done in all 140 cases and aspirate with biopsy was
performed in 130 cases. The reporting pathologists were
blinded to the results of the vitamin assays and were
provided with clinical data and hematology reports. The
diagnostic classiﬁcation for haematological diseases by the
World Health Organization was followed in all cases. We
found bone marrow aspirate alone corresponded with the
diagnosisinonly98/140(70%)patientswhilebiopsyallowed
better assessment of cellularity, ﬁbrosis, and extent of bone
marrow involvement, in addition to diagnosing 126/140Anemia 5
(90%) patients. The cellularity was increased in 100/140
(71%),decreasedin25/140(17%),andwasnormalin15/140
(10%) cases. The marrow was hypocellular in all cases of
aplastic anemia, 25% of leukemia patients, and up to 26%
ofpatientswithinfections.Ineﬀectiveerythropoesiswasseen
in megaloblastic anemia; erythroid hyperplasia was reported
in 60% of patients with 49% showing mild and 29% showing
moderate-to-severedyserythropoesis.Theerythroidreaction
was macronormoblastic in 29% and megaloblastic in 50%
cases in this group. Dysmyelopoesis was seen in 34% of
MA patients. Bone marrow inﬁltration was seen in leukemia
and lymphoma in which blast cells replace the hematopoetic
precursors. We also encountered two cases of metastatic
cancer-gastric signet cell cancer, and anaplastic carcinoma
with marrow involvement. Myelodysplastic syndrome was
detectedinonepatientbutnodysmyelopoesiswasseeninthe
marrow. Bone marrow involvement was seen in all the three
patients of disseminated tuberculosis (TB) who presented
with pancytopenia. In one of these patients, polymerase
chain reaction (PCR) on marrow aspirate for TB was
positive on the bone marrow aspirate and while granulomas
with caseation were seen in all three. Storage disorders
exhibit bone marrow inﬁltration and hypersplenism due to
marked splenomegaly. Hypersplenism was seen with visceral
leishmaniasis,chronicmalaria,andwithchronicliverdisease
with portal hypertension. Decreased iron stores were seen
in 15% of cases with megaloblastic anemia. Bone marrow
iron stores were comparable with serum ferritin in cases of
megaloblastic anemia, aplastic anemia, and myelophthisis.
However, serum ferritin was found to be elevated in cases of
leukemiaandinfections,especiallycasesofsepsisanddidnot
always correlate with stained marrow iron status so results
need to be interpreted carefully.
3.3. Biochemical Tests. Total bilirubin was elevated in 25% of
all patients while 17% of pancytopenic patients had icterus.
Of the 20 patients with indirect hyperbilirubinemia, 12 (60%
of all) belonged to MA group (P = 0.01). Total protein was
low in just three patients. Hypoalbuminemia was common
in the group with infections aﬀecting nearly 35% of patients.
Interestingly about 18% of patients of both MA and aplastic
anemia had hypoalbuminemia. Hypergammaglobulinemia
(>4.2g/dL) was not found in any patient in this study.
LDH was elevated in up to 46% of all patients including
40% of MA and 46% of leukemias. This parameter has
been found to correlate with disease and response to
therapy in other studies. An elevated LDH level (>250IU/L)
signiﬁcantly correlated with a diagnosis of MA as compared
with nonmegaloblastic pancytopenia (rank correlation r =
0.91) [7, 8].
3.4. Vitamin Assays in Pancytopenia. On evaluating the
vitamin levels in patients of MA versus other pancytopenic
patients, B12 levels were statistically lower and homocysteine
levels statistically elevated in MA (P<0.001) (See Table 3).
T h em e a nl e v e l so ff o l i ca c i da n df e r r i t i nw e r ec o m p a r a b l e
in both groups. We noted that patients with bleeding
manifestations had a lower serum ferritin. Iron deﬁciency
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Figure 3: Severity of Vitamin B12 deﬁciency in pancytopenia.
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as deﬁned by serum ferritin <12ng/mL or depleted bone
marrow iron was found in 17.14% cases. Mean ferritin levels
in patients with bleeding (32.3 ± 18.4ng/mL) was found
to be lower than in those without (42.9 ± 34.9ng/mL)but
the diﬀerence was not statistically signiﬁcant. It was found
that 81% of all patients had severe B12 deﬁciency (B12 <
100pg/mL)including91.6%ofpatientswithMA.Incontrast
to this, only 7.14% of all patients were folate deﬁcient. Folate
deﬁciency <5n g / m Lw a ss e e ni nj u s t7 %M Ap a t i e n t s( s e e
Figures 3 and 4).
3.5. Dietary Associations of Pancytopenia. The majority
(71.4%) of patients were lactovegetarian. There were no
vegans in this study and very few patients with frequent
nonvegetarian intake. The lactovovegetarian (12.9%) cases
behaved similar to the infrequently nonvegetarian group.
Only 15.7% of patients consumed ﬁsh, meat, and poultry.
On comparing the hematological parameters with diet, no
signiﬁcant diﬀerence was found in the mean Hb, TLC, and
platelet count levels in the lactovegetarians and nonvege-
tarian subgroups. The RDW, S. ferritin and RBC indices
in both groups were comparable. The mean B12 level in6 Anemia
Table 3: Vitamin assays in pancytopenia.
MA AA Leukemia Infections Myelo pthisis Other All Pancyto-
penia
Mean ± Standard deviation (SD)
S. Ferritin (ng/mL) 38.3 ±33.54 1 .2 ±33.45 5 .6 ±32.55 2 .5 ±40.45 7 .7 ±41.03 5 ±29.24 2 .9 ±34.9
Vitamin B12 (pg/mL) 83.4 ±59.2 220.3 ±379.3 219.3 ±536.1 155.5 ±224.37 2 .3 ±26.6 1152.1 ±
2158.7 150.3 ±426.8
Serum folate (ng/mL) 16.1 ±4.51 5 .7 ±1.99 .2 ±4.78 .8 ±9.98 1 .5 ±109.75 7 .4 ±101.71 7 ±4.3
S. Homo-cysteine
(µmol/L) N = 38 85.5 ±33.46 8 ±68 49.2 ±48.04 8 .8 ±27.0— 3 3 ±1.41 73.6 ±36.8
S. LDH (IU/L) 604.8 ±618.2 278.2 ±102.7 368.4 ±112.1 194.3 ±98 256.2 ±87.4 401.5 ± 101.4 473.98±764.8
MA: megaloblastic anemia; AA: aplastic anemia; LDH: lactate dehydrogenase.
all cases of pancytopenia was 157.6pg/mL (normal range
200–700pg/mL) and though mean B12 levels were found to
be higher in the non vegetarian population (169.3pg/mL)
as compared with vegetarian group (129.5pg/mL), this
diﬀerence was not statistically signiﬁcant and both groups
were found to have cobalamin deﬁciency. The folate and
LDH levels were, however, signiﬁcantly diﬀerent between the
vegetarian and nonvegetarian folate levels being lower and
LDH being higher in the vegetarian group. Another signif-
icant ﬁnding was 25.7% of all patients had received proton
pump inhibitor therapy (PPI). This included 23.5% patients
with megaloblastic anemia, 26% of leukemia patients, and
26% of patients with splenomegaly. However though the
MCV was higher and vitamin B12 levels lower in the
group consuming PPI, the diﬀerence was not statistically
signiﬁcant. Also, 24.3% of patients consumed tobacco in
some form including 23% of patients with leukemia and
7.1% patients consumed alcohol.
3.6. Neurological Features. In this series of 140 patients,
26.4% of all patients had neurological and/or psychiatric
complaints including symptoms of depression, memory loss
and irritability, which included 22% of all MA patients.
Notably, up to 40% of patients with leukemia had con-
comitant depression at some point during the course of
illness requiring psychiatric referral and treatment. Sub-
jective motor weakness (7%) and gait ataxia (12%) were
reported by patients with MA. Sensory deﬁcits of impaired
vibration sensation and joint position sense were found in
8.2% cases. Objective motor weakness was found in 7.1% of
these patients. These subjects underwent nerve conduction
studies (NCS) and 8 cases of demyelinating peripheral
neuropathy were detected. Most subjects with B12-deﬁcient
MA reported a subjective improvement in their symptoms
of memory loss and mood after cobalamin therapy. There
was complete or partial recovery in the motor and sensory
neuropathic complaints at 3 months after therapy in subjects
with cobalamin deﬁciency, with conversion to a normal NCS
in 3 cases where the test was repeated.
3.7. Other Tests. Splenic aspirates were performed in two
patients of visceral leishmaniasis whose marrow aspirates
were negative, which showed the characteristic LD (leish-
mania donovani) bodies. Diagnostic lymph node biopsy
was done in four cases of HIV AIDS with disseminated
tuberculosis, all of which showed caseation and poorly
formed granulomas; and in one case of non Hodgkin’s
lymphoma.Allpatientsofaplasticanemiainthisstudytested
negative for hepatitis B and C and HIV. Parvovirus B19
serology was done in ﬁve patients but was negative in all of
them.
3.8. Patient Outcome and Followup. Eighty-six (61.4%) of
the patients reported back to the outpatient department
after discharge including 55/85 (64.7%) with MA who were
on injectable B12 therapy, 6/13 (46.2%) of leukemia who
were on chemotherapy, 14/23 (60.8%) with infections, 8/11
(71.1%) with aplastic anemia, and 2/4 (50%) with myeloph-
thisis. Eight patients had expired in the ﬁrst admission itself
including three cases of leukemia, both cases of metastatic
carcinoma, two cases of HIV AIDS with tuberculosis, and
one case of chronic malaria. Of the ﬁfty-ﬁve cases with MA,
only forty reported regularly for followup at the end of
one year and had a good symptomatic and hematological
recovery. On examination of these patients, all but two
patientsshowedregressionofsplenomegalybythreemonths.
Knuckle hyperpigmentation was found in just 8.3% of MA
patients on followup as compared to 18.8% patients at
presentation.
Eight cases of acute leukemia received induction chem-
otherapy and six achieved remission. However, only four of
these patients survived at the end of two years; of which two
had suﬀered a relapse and were referred for bone marrow
transplantation (BMT). Of the eleven cases of aplastic
anemia, nine were managed with immunosuppressants or
antithymocyte globulin and supportive therapy, and all
survivedattheendofoneyear.Twopatientswerereferredfor
BMT. Of the surviving six cases with HIV AIDS, two expired
at the end of one year while the others achieved hematologi-
cal recovery and were on regular followup. All eight cases of
leishmaniasisreceivedamphotericinBtherapyandrecovered
completely. All three cases of disseminated tuberculosis were
managed with ATT (antitubercular therapy) but only two
were on followup after four months. Subjects with vitamin
deﬁciencyweretreatedwithoraland/orinjectablecobalaminAnemia 7
and folate therapy in addition to therapy for the primary
disease.
Table 4 on the hematological aspects on followup shows
signiﬁcant changes in Hb, TLC, platelet count, MCV, MCH
and reticulocyte count when compared with Table 2 which
shows the same parameters at the time of presentation. The
mean Hb improved to 12.3 ± 0.97g/dL in MA and to 9.4 ±
2.0g/dLinAA.ThemeanRDWwas16atpresentationwhich
was corrected with therapy to a mean value of 12.82±1.11 in
MA. Likewise mean LDH was 604.8±618IU/L at the time of
presentation which improved to 89.0±33.7IU/L at followup
in MA corroborating earlier studies stating that LDH may be
used as a marker of response to therapy.
4. Discussion
Six broad diagnostic groups could be identiﬁed in pancy-
topenia. Megaloblastic anemia constituted the largest group
comprising 60.7% of all cases. Aplastic anemia (7.8%),
leukemia (9.2%), and infections (16.4%) were the next most
common causes.
4.1. Other Studies in India. A number of studies have been
done on pancytopenia in India documenting the geographic
and demographic trends of this diverse disease process. In
a study at Chandigarh, the most common cause of pancy-
topeniaasrevealedbybonemarrowexaminationwasaplastic
anemia (40.6%) followed by megaloblastic anemia (23.26%)
[9]. Another study at New Delhi found megaloblastic ane-
mia, aplastic anemia, leukemia, myelodysplastic syndrome,
paroxysmal nocturnal hemoglobinuria, overwhelming viral
infections,anddrug-inducedpancytopeniaasthemostcom-
monly diagnosed causes of pancytopenia [10]. In contrast
a recent study from eastern India has reported aplastic
anemia (20.72%) as the commonest cause, followed by
hypersplenism due to chronic liver disease (11.71%) and
leishmaniasis (9%) [11] (see Table 5).
These diﬀerences in the etiology of pancytopenia are
due to diﬀerences in population characteristics such as, age
patterns, nutritional status, socioeconomic parameters and
the prevalence of infections in a geographic region [9–13].
Since our study excluded patients aged less than 18 years,
the number of aplastic anemia cases was reduced as a large
proportion of this disease aﬀects patients in the second
decade which would be considered in the pediatric category.
This correlates with the ﬁnding that studies with younger
subjects have reported aplastic anemia more commonly.
Similarly other studies included recipients of cytotoxic
drugs and chemotherapy and therefore reported marrow
hypoplasia as being common. This group was speciﬁcally
excluded in our study as the etiology of marrow suppression
due to primary disease or chemotherapy is unclear in such
cases. Also, our patient population was mainly of the lower
socioeconomic status, and the cobalamin deﬁciency may be
attributed to an inadequate diet. This fact partially explains
the higher proportion of MA cases in the present study. We
were also stringent in the application of the exclusion criteria
and cases who received blood transfusions and injectable
drug therapy elsewhere were not included as these would
have aﬀected vitamin assays and marrow morphology.
Ours being a referral tertiary care hospital, we saw cases
from all over north India. The prevalence of infections in a
communitysuchasmalaria,kalaazar,HIVAIDS,andenteric
fever varies from region to region. Of the eight patients with
HIV, seven had concomitant tuberculosis. While HIV per
se can cause myelosuppression, the presence of TB in these
patients may have added further to the marrow dysfunction
resulting in pancytopenia. More cases of HIV AIDS with
pancytopenia were encountered but they were excluded as
many had received blood transfusions prior to referral or
were too ill for the proposed work up.
4.2. Studies in Other Countries on Pancytopenia. An u m b e r
of studies have been done in other countries reﬂecting
the importance of socioeconomic and geographic param-
eters on the etiology of this condition. Infections such as
tuberculosis, HIV, and vitamin deﬁciencies are treatable and
frequent causes of pancytopenia in developing countries.
This contrasts with studies in the developed world where
the bulk of disease is due to malignancy or marrow aplasia
[15–21]. A study in Zimbabwe concluded that megaloblastic
anemia, aplastic anemia, and AIDS are the most com-
mon causes of pancytopenia [16]. Aplasia was the most
frequent cause of severe pancytopenia. In a study done
in Pakistan in 2001, megaloblastic anemia, hypersplenism
and aplastic anemia were the main causes of pancytopenia
[17]. In contrast, a French review of 213 consecutive adult
pancytopenics showed malignant myeloid disorders (acute
myeloid leukemias, MDS, and myeloﬁbrosis) represented
42% and various malignant lymphoid disorders 18% of the
cases. Aplastic anemia (10%), vitamin deﬁciencies (7%) and
nonhematological pathology (10%) were other causes [18].
Bone marrow examination concurred with the clinical
diagnosis in 126/140 patients, that is, almost 90 percent. In
some cases, when the ﬁrst bone marrow aspirate was not
diagnostic or showed hemophagocytic syndrome, a second
aspirate and biopsy was performed and more often than
not clinched the diagnosis. This was especially so with cases
of focal deposit disorders like lymphoma and metastatic
carcinoma, and infections like kala-azar, tuberculosis, and
chronic malaria. We also noted two cases of aleukemic
leukemia and a case of lymphoma which were masquerading
as refractory MA on basis of vitamin B12 assays and bone
marrow aspirates. These three cases were however excluded
from the study because they received prior treatment
including blood transfusions elsewhere before referral to our
hospital. This highlights the necessity of a good specimen of
aspirateandbiopsyinmarrowexaminationinrefractoryMA
or pancytopenia.
4.3. Vitamin Assays. Severe cobalamin deﬁciency (serum
B12 < 100pg/mL) was seen in 81% of all patients including
91.6% of patients with MA, the lowest level being 53pg/mL.
Only 12% of patients had levels above 200pg/mL. Vitamin
B12 levels were signiﬁcantly lower in MA as compared
with the other groups. In contrast to this, only 7.1% of all8 Anemia
Table 4: Hematological parameters of patients at follow up.
MA AA Leukemia/lymphoma Infections Myelophthisis Other
All
Pancyto-
penia
P value†
N = 55 N = 8 N = 6 N = 12 N = 2 N = 3 N = 86
Mean ± standard deviation
Hb (g/dL) 12.3 ±0.99 .4 ±2.01 2 .8 ±0.91 2 .3 ±1.31 0 .1 ±4.61 1 .1 ±1.41 2 .0 ±1.5 0.001
TLC (×109 cells/l) 7.5 ±1.95 .1 ±2.18 .2 ±2.47 . 0 ± 2.6 6.6± 4.5 6.1± 1.4 7.2± 2.2 0.001
Platelets (×109
cells/L) 267 ±88 255 ±138 256 ±78 249 ±69 180 ±71 287 ±142 262 ±91 0.001
ANC (×109 cells/L) 5.5 ±1.53 .5 ±1.55 .8 ±1.74 .8 ±1.84 .9 ±4.14 .3 ±1.65 .2 ±1.7 0.001
RDW 12.8 ±1.11 2 .2 ±0.61 3 .4 ±1.21 2 .6 ±1.11 2 .8 ±2.21 3 .1 ±1.71 2 .7 ±1.1 0.132
MCV (ﬂ) 85.9 ±6.78 6 .6 ±4.79 1 .5 ±4.98 6 .1 ±6.89 2 .5 ±2.48 8 .3 ±4.08 6 .6 ±6.4 0.044
MCHC 33.7 ±1.73 2 .5 ±1.83 3 .2 ±1.73 4 .0 ±1.33 3 .5 ±1.23 2 .8 ±1.33 3 .5 ±1.6 0.476
MCH (pg) 29.6 ±2.22 8 .7 ±2.42 9 .4 ±2.53 0 .6 ±3.13 1 .2 ±1.22 8 .4 ±3.82 9 .7 ±2.4 0.001
Retic count
corrected 3.2 ±1.11 .7 ±1.54 .0 ±1.42 .6 ±1.22 .7 ±0.73 .5 ±0.33 .1 ±1.3 0.000
Hb: hemoglobin; TLC: total leukocyte count; AEC: absolute eosinophilcount; ANC: absolute neutrophilcount; RDW: red cell distribution width; MCV:mean
corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; Retic count: reticulocyte count; LDH:
lactate dehydrogenase.
†Student’s t-test for signiﬁcant diﬀerence of means at presentation and on follow up.
pancytopenic patients were folate deﬁcient. Folate deﬁciency
<5ng/mL was seen in just 5% MA patients. Combined
deﬁciency of cobalamin and folate was seen in just 5
patients, that is, (3.5%). The mean levels of serum folate did
not signiﬁcantly diﬀer between the diagnostic groups and
also there was no statistical diﬀerence between folate lev-
els in megaloblastic versus nonmegaloblastic pancytopenic
patients. The issue of the low frequency of folate deﬁciency
in this study can be explained by various factors. Firstly,
recipients of blood transfusion and injectable drug therapy
were excluded as these would have aﬀected vitamin assays.
However, oral folic acid or multivitamin supplementation
prior to presentation at our centre may have resulted in
normal folate levels as even a single folate-rich meal can
change serum concentration [22]. Secondly, cobalamin and
folate measurements in serum show wide intermethodology
variability partly due to usage of inadequate standards
and diﬀerent techniques like radioimmunoassay (RIA) and
microbiological methods. The World Health Organisation
(WHO) Expert Committee on biological standardization
established lyophilized pooled serum IS 03/178 as the ﬁrst
international reference standard for B12 and folate using
candidate reference methods based on LC-MS/MS to reduce
interlaboratory variability [23]. The RIA technique (Bio-Rad
QuantaPhase II) used in the United States National Health
and Nutrition Examination Surveys (NHANES) for 25 years
is now being phased out to be replaced by LC-MS/MS for
folateestimation[24].Moreoverserumcobalaminlevelsmay
not be indicative of actual deﬁciency. Cobalamin levels may
befalselyhighinpatientswithmegaloblastosisduetonitrous
oxide, transcobalamin II (TCII) deﬁciency, inborn errors in
cobalaminmetabolism,andmyeloproliferativedisorders.On
the other hand, serum cobalamin levels can be falsely low
within some patients with folate deﬁciency, individuals on
high doses of ascorbic acid, pregnant women, and persons
withtranscobalaminI(TCI)deﬁciency[25,26].Soclinicians
need to interpret results carefully.
Nonetheless, another hospital-based study done in Delhi
on 107 patients of MA revealed cobalamin deﬁciency in 78
patients (65%), combined cobalamin and folatedeﬁciency in
20 patients (12%), and pure folate deﬁciency in 8 patients
(6%) indicating a similar pattern [27]. Another study
on asymptomatic adults in Delhi revealed that 46.9% of
“normal” subjects had subnormal levels of serum cobalamin
orfolate,cobalamindeﬁciencybeingﬁvetimesascommonas
folate deﬁciency [28]. Further population-based studies are
therefore required before conclusions are generalized. Serum
homocysteine was done in only 38 patients including 26 with
MA. It was elevated in all MA patients as compared with
the rest and the diﬀerence was statistically signiﬁcant (P =
0.002). Of the megaloblastic patients with hyperhomocys-
teinemia, 19 (73%) were vegetarian. A recent study reported
≈75%ofaselectedurbanpopulationfromwesternIndiahad
metabolic evidence (hyperhomocysteinemia and methyl-
malonic acidemia) consistent with cobalamin deﬁciency that
can only partly be explained by a vegetarian diet [29].
In recent years, there has been a growing interest in the
vitamins folic acid and cobalamin because of the realization
that the status of the vitamins in populations is less than
adequate, and that such inadequacy may be linked to adverse
public health outcomes. This concern has prompted several
countries like the United States, Canada, and so forth to
fortify food grain products with folate, while additional
countries are considering doing so in the near future [30].
4.4. Dietary Factors. Vegetarians comprised 71% of all pa-
tients. Though the majority of MA patients were lactovege-
tarians, a good 29% were consuming a nonvegetarian diet.Anemia 9
Table 5: Indian studies on pancytopenia.
S. No. Study; location Year Age group
(years) No. of cases
Commonest
cause of
pancytopenia
2nd most
common
cause
Other causes
1
Varma and
Dash;
Chandigarh [9]
1992 Adults 202 AA (40%) MA (23%) AML, lymphoma.
2
Tilak and Jain;
Chandigarh
[12]
1999 5–70 77 MA (68%) AA (7%)
Malaria, KZ, NHL,
AML, MM, TB,
Waldenstrom’s
macroglobulinemia
3 Khodke et al.;
New Delhi [10] 2000 3–69 50 MA (44%) AA (14%)
KZ, MM, HIV, MDS,
AML, TB, Drug
induced cytopenia
4 Kumar et al.;
New Delhi [13] 2001 All ages 166 AA (29%) MA (22%) Aleukemic leukemia,
lymphoma
5 Khunger et al.;
New Delhi [14] 2002 2–70 250 MA (72%) AA (14%)
Aleukemic leukemia,
MDS, KZ, malaria,
NHL, TB,
myeloﬁbrosis, MM
6 Santra and Das;
Kolkata [11] 2010 13–65 111 AA (22%)
Hyper-
splenism due
to CLD
(11%)
MA, SLE, Drug
induced cytopenia,
falciparum malaria,
TB, CLL, MM, MDS,
PNH, Felty’s
syndrome.
7 Present study;
New Delhi 2008 18–80 140 MA (60%)
Leukemia
(9%), AA
(8%)
HIV, TB, KZ, Malaria,
MDS, CML,
Gaucher’s disease,
metastatic carcinoma,
CLD with
hypersplenism.
MA: megaloblastic anemia; AA: aplastic anemia; AML: acute myelogenous leukemia; KZ: kala-azar; MM: multiple myeloma; HIV: human immunodeﬁciency
virus; MDS: myelodysplastic syndrome; TB: disseminated tuberculosis; NHL: non Hodgkin’s lymphoma; CLL: chronic lymphatic leukemia; PNH: paroxysmal
nocturnal hemoglobinuria; CML: chronic myelogenous leukemia; CLD: chronic liver disease.
We wish to emphasise here that B12 deﬁciency should not
be assumed to aﬀect vegetarians only as the frequency of
consumption of nonvegetarian food intake was found to be
low even in the non vegetarian group which might explain
the high frequency of B12 deﬁciency in this study. This
important facet of the north Indian dietary habit needs to
be considered in any analysis of vitamin/diet deﬁciency while
comparing with western data or with reports from the other
parts of the country [31].
Other than a vegetarian diet, the cause of cobalamin
deﬁciency in the subjects in the current study was not
clear. Tropical sprue, giardiasis, and other gastrointestinal
infections are common in India, and these may lead to mal-
absorptive states and cobalamin deﬁciency. We did perform
barium studies and upper gastrointestinal endoscopy with
biopsies in symptomatic patients but the yield of such tests
remains low [32, 33]. Further evaluation of the cause of B12
deﬁciency is required in such cases including anti-intrinsic
factor or antiparietal cell antibody tests and evaluation of
genetic and familial disease.
5. Conclusion
Pancytopenia has multiple etiologies. Data regarding pan-
cytopenia in an adult Indian population is lacking which
prompted this study. People in India and other developing
nations continue to suﬀer from vitamin deﬁciencies which
cause anemia and pancytopenia. These are easily preventable
if diagnosed and treated early. Better health awareness
will reduce the burden of disease. Infectious diseases like
tuberculosis, kala-azar, and increasingly HIV are important
and treatable causes. This is in contrast with the developed
nations where the bulk of disease is due to malignancy
or marrow aplasia. A careful and individualized approach
to the diagnosis and management of this condition is
needed (See Figure 5). The role of dietary deﬁciency of10 Anemia
Clinical assessment followed by complete hemogram with diﬀerential count, peripheral
smear, corrected reticulocyte count, RBC indices, and morphology of cells.
Diagnosis of pancytopenia
• Hb <11 g/dL in males and <10 g/dL in females
Hypocellular bone marrow Cellular bone marrow
￿ Acquired aplastic anemia
￿ Constitutional aplastic anemia
￿ PNH
￿ Leukemic blast cell morphology, special stains., 
CD markers
￿ Bone marrow lymphoma
Assess for
Primary bone marrow disease
Secondary to systemic disease
Megaloblastic anemia  Infections
￿ Vitamin B12 and folate assays
￿ Antiparietal cell antibody
￿ Evaluation for giardiasis, tropical sprue
￿ Drug exposure
￿ Viral serology for HIV, HBV, HCV,
Dengue, and parvovirus B19
￿ Widal test, blood culture for
enteric fever
Immunological causes and hypersplenism
￿ Systemic lupus erythematosus
￿ Hypersplenism due to CLD
￿ Overwhelming infection
￿ Sarcoidosis
￿ LD bodies for kala-azar
￿ Malarial pigment and parasite
￿ Bone marrow granulomas; AFB stain,
PCR for TB
Morphology: dysplastic
changes, inﬁltration by
leukemia, lymphoma, and multiple
myeloma
￿ Myelodysplastic syndrome
￿ Leukemia/Lymphoma
Bone marrow aspirate +/− trephine biopsy
￿ Total leukocyte count <4 ×109 cells/L
￿ Platelet count <150 ×109/L.
Hb: hemoglobin
RBC: red blood cell
PNH: paroxysmal nocturnal hemoglobinuria
CD: cluster of diﬀerentiation
HIV: human immunodeﬁciency virus
HBV: hepatitis B virus
HCV: hepatitis C virus
LD: Leishmania donovani bodies
AFB: acid fast bacillus
PCR: polymerase chain reaction
CLD: chronic liver disease
Figure 5: Algorithmic approach to the investigation of pancytopenia.
cobalamin cannot be emphasized enough, even in nonveg-
etarian patients as subclinical deﬁciency is common in the
Indian population and manifests with both hematological
and neurological consequences. Our study revealed that
multifactorial causation for pancytopenia in our patient
population is probable and occult cobalamin deﬁciency may
contribute to the burden of hematological disease in patients
with other primary diagnoses. Therefore B12 status needs to
be assessed either clinically or by laboratory methods in high
risk groups, and also in case of poor response to primary
therapy. Cobalamin (either oral or parenteral) and folic acid
therapy should be considered in addition to treatment for
the primary diagnosis, depending on the clinical scenario.
Concerns raised about the risks of unmasking undiagnosed
B12 deﬁciency in the age of folate supplementation are
compelling especially in the Indian population. Further
recommendations regarding folate or B12 supplementation
in the general population can only be made after more
population-based studies are completed.
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